论文信息 - An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function. - 字舞流文

An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function.

H. Matsuoka | Y. Shimono | Aki Inase | H. Minami | T. Sonoki | A. Kitao | Yasuyuki Saito | Y. Miyata | Seiji Kakiuchi | Y. Mizutani | Y. Saito | Yimamu Maimaitili